[Results of clotrimazol therapy in candida and trichomonas infections].
D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000009:adverse effects / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D009092:Mucous Membrane / Q000187:drug effects; D011537:Pruritus / Q000188:drug therapy; D014245:Trichomonas Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles
Ergebnisse der Clotrimazol-Therapie bei Candida- und Trichomonas-Infektionen